Cargando…

Variability in Antithrombotic Therapy Regimens Peri-TAVR: A Single Academic Center Experience

INTRODUCTION: The aim of this study was to describe peri-procedural antithrombotic use in patients undergoing transcatheter aortic valve replacement (TAVR) at a single academic medical center. METHODS: Retrospective collection of antiplatelet and anticoagulant use during the index hospitalization fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossi, Jeffrey E., Noll, Andrew, Bergmark, Brian, McCabe, James M., Nemer, David, Okada, David R., Vasudevan, Anant, Davidson, Michael, Welt, Frederick, Eisenhauer, Andrew, Shah, Pinak, Giugliano, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2015
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675746/ https://www.ncbi.nlm.nih.gov/pubmed/26399647 http://dx.doi.org/10.1007/s40119-015-0050-2

Ejemplares similares

Impact of Antithrombotic Regimen on Mortality, Ischemic, and Bleeding Outcomes after Transcatheter Aortic Valve Replacement
por: Varshney, Anubodh, et al.
Publicado: (2018)

How to succeed in academics
por: McCabe, Edward R B, et al.
Publicado: (2000)

Jacket of guidewire detaching during interventional closure for peri-valvular leak after VIV TAVR
por: Wang, Juan, et al.
Publicado: (2022)

Prognostic value of dual T1 mapping to predict adverse events in TAVR-patients: extra cellular volume as a possible predictor for peri- and post-TAVR adverse events
por: Nadjiri, Jonathan, et al.
Publicado: (2016)

Thoracic Aorta Perforation Treated Conservatively After TAVR in a Patient With Extremely Tortuous Aorta
por: Manevich, Lisa, et al.
Publicado: (2022)

Bioprosthetic Valve Fracture After TAVR Complicated by Balloon Rupture: Bail-Out TAVR in TAVR in SAVR
por: Attisano, Tiziana, et al.
Publicado: (2022)

Smoking and TAVR
por: Edelman, J. James, et al.
Publicado: (2019)

TAVR for All? The Surgical Perspective
por: Zhang, Xiling, et al.
Publicado: (2022)

Coronary Angiography After Transcatheter Aortic Valve Replacement (TAVR) to Evaluate the Risk of Coronary Access Impairment After TAVR‐in‐TAVR
por: Nai Fovino, Luca, et al.
Publicado: (2020)

The TAVR that Got Away: A Case Report
por: Boshara, Andrew, et al.
Publicado: (2020)

TAVR: nemesis of NOACs?
por: Polzin, Amin, et al.
Publicado: (2022)

Degenerated TAVR Within Degenerated Surgical Bioprosthetic Valve Treated With Second TAVR
por: Ajmal, Muhammad, et al.
Publicado: (2020)

Development of New Antithrombotic Regimens for Patients with Acute Coronary Syndrome
por: George, Sudhakar, et al.
Publicado: (2019)

Bailout From Sinus Jailing: In-Series TAVR-in-TAVR to Avoid Coronary Flow Obstruction
por: Casenghi, Matteo, et al.
Publicado: (2021)

Embolic protection device, the next advancement in TAVR?
por: Li, David, et al.
Publicado: (2020)

Tips and Tricks in Transaortic TAVR
por: Gennari, Marco, et al.
Publicado: (2022)

Supporting patients in the transition to the revised pexidartinib dosing regimen: perspectives from the multidisciplinary clinical and allied health professional team
por: McCabe, Colleen, et al.
Publicado: (2023)

Temporal Trends in Internal vs. External Referrals for TAVR in a Large Academic Center: Patients Characteristics and Outcomes
por: Merlo, Aurelie, et al.
Publicado: (2022)

The Pivotal Role of Imaging in TAVR Procedures
por: Bleakley, Caroline, et al.
Publicado: (2018)

Challenging Anatomies for TAVR—Bicuspid and Beyond
por: Saad, Mohammed, et al.
Publicado: (2021)

Commentary: Surgical explant of TAVR prostheses
por: Edelman, J. James, et al.
Publicado: (2020)

The Miraculous Journey of TAVR: Beware of Rare!
por: Akhtar, Mohammed A., et al.
Publicado: (2019)

Preoperative TAVR Planning: How to Do It
por: Saadi, Rodrigo Petersen, et al.
Publicado: (2022)

TAVR and stroke: A common evolution
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

New adverse coronary events in valve-in-valve TAVR and native TAVR—A 2-year matched cohort
por: Koren, Ofir, et al.
Publicado: (2022)

White paper on mitigating risk factors for acute kidney injury in TAVR: A protocol to decrease TAVR-associated AKI
por: Singh, Sohrab, et al.
Publicado: (2023)

Risk of Bleeding after Transcatheter Aortic Valve Replacement: impact of Preoperative Antithrombotic Regimens
por: Albabtain, Monirah A, et al.
Publicado: (2022)

Imaging in Transcatheter Aortic Valve Replacement (TAVR): role of the radiologist
por: Litmanovich, Diana E., et al.
Publicado: (2014)

TAVR and SAVR: Current Treatment of Aortic Stenosis
por: Hu, Patrick P.
Publicado: (2012)

Ferumoxytol MR angiography for pre-TAVR assessment
por: Finn, J Paul, et al.
Publicado: (2016)

The development of transcatheter aortic valve replacement (TAVR)
por: Cribier, Alain
Publicado: (2016)

Patient Prosthesis Mismatch After SAVR and TAVR
por: Bleiziffer, Sabine, et al.
Publicado: (2022)

What’s New with TAVR? An Update on Device Technology
por: Zaid, Syed, et al.
Publicado: (2023)

The Management of Coronary Artery Disease in TAVR Patients
por: Faroux, Laurent, et al.
Publicado: (2023)

Differences in Inpatient Outcomes After Surgical Aortic Valve Replacement at Transcatheter Aortic Valve Replacement (TAVR) and Non‐TAVR Centers
por: Jack, Godly, et al.
Publicado: (2019)

TAVR: A Review of Current Practices and Considerations in Low-Risk Patients
por: Spears, Jenna, et al.
Publicado: (2020)

Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention
por: Parikh, Shailja V, et al.
Publicado: (2009)

Development of a Novel Apigenin Dosage form as a Substitute for the Modern Triple Antithrombotic Regimen
por: Tsiailanis, Antonios D., et al.
Publicado: (2023)

The safety of introducing a new generation TAVR device: one departments experience from introducing a second generation repositionable TAVR
por: Bjursten, Henrik, et al.
Publicado: (2017)

Post Transapical Aortic Valve Replacement (TAVR) Pseudoaneurysm
por: Manning, Michael W., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qs4mvrjq9akcbr8nji9s3i9l7v